PrivCo Logo

ProductPricingContactLogin

Vaccination Rush 💉

Vaccination Rush 💉
November 12, 2020

The Daily Stack is a daily market insight newsletter by PrivCo, a private market intelligence platform.

For a limited time, subscribe to PrivCo for $199/month for three months compared to $299/month.

Vaccination Breakthrough
While the Pfizer/BioNTech vaccine breakthrough is rippling a new wave of hope in the battle against COVID-19, a number of private biotech companies are also ramping up vaccination development programs to battle the pandemic. While the vaccine-creation process is time-consuming, numerous startups are using their expertise and capabilities to find and develop technology-driven solutions targeting the virus at different stages and using different methodologies. Here’s a list of companies that have caught mainstream and investor attention in their fight against COVID-19.

HTD BioCorp 

  • This Seattle biotech company received a government grant from the National Institutes of Health (NIH) of $8.3MM in September and in October earned another $3MM in seed funding led by Zoic Capital.
  • The funds will be used to support the continued development of its COVID-19 vaccine candidate, HDT-301, and is slated to enter clinical trials in Q4 in partnership with the NIH/NIAID.

Codagenix

  • A small and mighty 11 person team from Long Island, NY is developing a vaccine made from a live-attenuated (aka weakened) version of the COVID-19 virus. 
  • It received $20MM in Series B funding in January this year. 
  • The company is also slated to start clinical trials soon after promising animal testing results. A live version of the virus is said to provide stronger protection in the long run. 

Meissa Vaccines

  • San Francisco-based Meissa is starting preclinical studies and manufacturing of a vaccine against COVID-19. Like Codagenix, the virus will be live attenuated but will be delivered through the nose instead. 
  • The company’s last round of funding was a Series A funding in September 2019 of $30MM. 

Buoy Health

  • Although not focused on vaccination treatment but rather a healthcare navigation tool powered by AI, the company offers COVID-19 assessment tools that ultimately directs patients to healthcare treatments and is said to have assessed 1 million Americans during the pandemic. 
  • The company received a $37.5MM Series C funding on Tuesday, November 10 from Cigna Ventures, Humana, and Optum Ventures, rare funding from multiple health insurance companies. 
Superspreading at gyms and restaurants
New studies take a look at where COVID-19 was most easily spread.
[Read more]
Mobility hub for flying taxis in Florida 
German flying taxi startup Lilium announced plans to launch its first US hub with plans to connect Florida residents and tourists..to Disney World?
[Read more]
Since last week, PrivCo has added:
563 Companies | 152 Funding Activities | 134 M&A Deals

Funding & Deal Highlights:

Hopin raises $125MM led by IVP and Tiger Global
Conference Software & Internet Services • Series B • London, UK

VF Corp acquires streetwear brand Supreme for $2.1BN
Apparel, Footwear & Accessories • Acquisition • Las Vegas, NV

Mschf Product Studio receives $200MM funding
Creative Studio • Equity • Brooklyn, NY

Better Mortgage receives $200MM led by L Catterton
Consumer Finance • Series D • New York, NY

MacroHealth receives $54MM CAD from multiple investors
Business Support Services • Equity • Kirkland, WA

Maestro raises $7.2MM led by S&P Global Market Intelligence
Consulting Software & Internet Services • Series A • New York, NY

Isovalent raises $29MM led by GV and Andreessen Horowitz
Cyber Security Software & Internet Services • Series A • Mountain View, CA

Venminder receives $33MM led by Silversmith Capital
Software & Internet Services • Series C • Elizabeth Town, KY

ScaleAI receives undisclosed funding raising it to a $3.2BN valuation
AI Software & Internet Services • Equity • San Francisco, CA

SugarCRM acquires W-Systems 
CRM Software & Internet Services • Acquisition • Cupertino, CA

Like this newsletter?
Forward to a friend!  Forward to a friend! 
Not a subscriber yet? Sign up here!
Website
Twitter
LinkedIn
Copyright © 2020 PrivCo Media, LLC. All Rights Reserved.
Unsubscribe | PrivCo.com | Contact Us